Former official David Mansdoerfer argues that bureaucratic delays at the FDA threaten American leadership in the growing regenerative medicine sector and give international competitors like China a strategic advantage.
Politics
·
To outcompete China, unhandcuff America’s biotech innovators
CN
CitrixNews Staff
Originally reported by The Hill. Read the full story at the original source.
Related Articles
Politics
Polanski says he will not overturn Green Party's 'Zionism is racism' motion
Image caption, Zack Polanski was interviewed by Laura Kuenssberg on Sunday morningByEwan SomervillePolitical reporterPub...
CitrixNews Staff
·
2 hours ago
Politics
Republicans warn that Pentagon funds will hinge on Trump getting tougher with Russia
A growing chorus of House Republicans is warning President Trump that they’re ready to block additional Pentagon funding...
CitrixNews Staff
·
2 hours ago
Politics
Across Farm Country, Economic Discontent Strains Republican Coalition
Farmers and ranchers have supported President Trump for a decade. But the war in Iran, tariffs and other administration ...
CitrixNews Staff
·
3 hours ago
Politics
Will Rural Voters Sit Out the Midterms?
Lisa Lerer, a national political correspondent, travels to a cattle auction in Calhan, Colo., to see if economic anxieti...
CitrixNews Staff
·
3 hours ago